Ryan D Drant's Net Worth

$572 Million

Estimate Recalculated Feb 20, 2024 05:28PM EST

Who is Ryan D Drant?

Ryan D Drant has an estimated net worth of $572 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., OPOWER, INC., Workday, Inc., Care.com Inc, Millennial Media Inc., AEROHIVE NETWORKS, INC, Echo Global Logistics, Inc., FOXHOLLOW TECHNOLOGIES, INC., FUSION-IO, INC., ARYx Therapeutics, Inc., PEPLIN INC, TriVascular Technologies, Inc., INNERWORKINGS INC, HYPERION THERAPEUTICS INC, SUPERNUS PHARMACEUTICALS INC, CHANNELADVISOR CORP, Groupon, Inc., Zosano Pharma Corp, Clovis Oncology, Inc., AMICUS THERAPEUTICS INC, BOX INC, Loxo Oncology, Inc., Dermira, Inc., CHAMPIONS ONCOLOGY, INC., TREVENA INC, ARDELYX, INC., GLYCOMIMETICS INC, Tracon Pharmaceuticals, Inc., Epizyme, Inc., SUNESIS PHARMACEUTICALS INC, Roka BioScience, Inc., Omthera Pharmaceuticals, Inc., Tableau Software Inc, CVENT INC, XOOM Corp, AUDIENCE INC, INTERLEUKIN GENETICS INC, and HEMOSENSE INC.

SEC CIK

Ryan D Drant's CIK is 0001302106

Past Insider Trading and Trends

2014 was Ryan D Drant's most active year for acquiring shares with 56 total transactions. Ryan D Drant's most active month to acquire stocks was the month of May. 2014 was Ryan D Drant's most active year for disposing of shares, totalling 68 transactions. Ryan D Drant's most active month to dispose stocks was the month of May. 2012 saw Ryan D Drant paying a total of $47,805,439.45 for 54,336,081 shares, this is the most they've acquired in one year. In 2015 Ryan D Drant cashed out on 12,788,047 shares for a total of $109,687,782.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AUDIENCE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-49.98%
-1.44M
$9.83
-$25,287.96
1.44M
Nov 4 - Nov 5
Form 4
-100.00%
-508.00
$14.04
-$7,132.37
0
Mar 11
Form 4
-100.00%
-2.79K
$12.96
-$36,186.83
0
Mar 7
Form 4
-32.65%
-1.40M
2.88M
Feb 15
Form 4
4.28M
4.28M
May 15
Form 3
0
0
No matching records found

SUPERNUS PHARMACEUTICALS INC (SUPN) Snapshot price: $27.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
10.64M
$5.00
10.64M
May 4
Form 3
0
0
No matching records found

HEMOSENSE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

OPOWER, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
8.99M
8.99M
Apr 9
Form 3
0
0
No matching records found

Zosano Pharma Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+20.33%
364.66K
$9.46
$3,448,256.35
2.16M
Jan 30
Form 3
0
0
No matching records found